Cargando…
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms
Protein marker levels in formalin-fixed, paraffin-embedded tissue sections traditionally have been assayed by chromogenic immunohistochemistry and evaluated visually by pathologists. Pathologist scoring of chromogen staining intensity is subjective and generates low-resolution ordinal or nominal dat...
Autores principales: | Peck, Amy R, Girondo, Melanie A, Liu, Chengbao, Kovatich, Albert J, Hooke, Jeffrey A, Shriver, Craig D, Hu, Hai, Mitchell, Edith P, Freydin, Boris, Hyslop, Terry, Chervoneva, Inna, Rui, Hallgeir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047958/ https://www.ncbi.nlm.nih.gov/pubmed/27312066 http://dx.doi.org/10.1038/modpathol.2016.112 |
Ejemplares similares
-
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment
por: Yang, Ning, et al.
Publicado: (2013) -
Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression
por: Sato, Takahiro, et al.
Publicado: (2013) -
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes
por: Peck, Amy R, et al.
Publicado: (2012) -
Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data
por: Yi, Misung, et al.
Publicado: (2023) -
High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer
por: Chervoneva, Inna, et al.
Publicado: (2023)